Velanki v. Hims & Hers Health, Inc.

What this case is about

Investors are suing Hims & Hers Health, a telehealth and personal care company, alleging that the company and its executives made false or misleading statements to the public about the company's business, financial performance, or prospects. Plaintiffs claim that when the truth about these misstatements came to light, the company's stock price dropped significantly, causing financial harm to shareholders. The proposed class consists of investors who purchased or acquired Hims & Hers Health securities during a specific period when the allegedly misleading statements were being made. This is a securities fraud case, not a traditional consumer product lawsuit, meaning the people seeking compensation are shareholders rather than customers who bought the company's health and wellness products.

What happens next

The case is in its earliest stage. The defendant has not yet responded. Class certification — the court's decision on whether the case can proceed as a class action — typically takes 12 to 24 months after filing. See our FAQ for how class actions work and what it means to be a class member.

Source: CourtListener docket entry. This summary was generated automatically from the public docket and has not been reviewed by an attorney. It may contain errors and may not reflect subsequent filings. Published by Access Law Group; responsible attorney Bogdan Enica, Esq..